跳转至内容
Merck
CN

主要文件

查看所有文档

420099

JAK抑制剂I

≥98% (HPLC), solid, JAK inhibitor, Calbiochem®

别名:

Janus蛋白酪氨酸激酶(JAK)抑制剂I, 2-（1，1-二甲基乙基）-9-氟-3，6-二氢-7H-苯并[h]-咪唑[4，5-f]异喹啉-7-酮，吡啶酮6，P6，DBI，JAK1抑制剂I，JAK2抑制剂I，JAK3抑制剂X

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:
C18H16FN3O
化学文摘社编号:
457081-03-7
分子量:
309.34
MDL number:
MFCD17019334
UNSPSC Code:
12352200
NACRES:
NA.77
Assay:
≥98% (HPLC)
Form:
solid
Quality level:
100
Storage condition:
OK to freeze, protect from light
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

JAK抑制剂I, JAK Inhibitor I, CAS 457081-03-7, is a potent, reversible, cell-permeable, and ATP-competitive inhibitor of JAK 1 (IC50 = 15 nM), JAK2 (IC50 = 1 nM), JAK3 (Ki = 5 nM) and Tyk2 (IC50 = 1 nM).

Quality Level

100

assay

≥98% (HPLC)

form

solid

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze, protect from light

color

off-white to light brown

solubility

DMSO: 5 mg/mL

shipped in

ambient

storage temp.

−20°C

SMILES string

Fc1cc2c(c3[nH]c(nc3c4c2c(ncc4)O)C(C)(C)C)cc1

InChI

1S/C18H16FN3O/c1-18(2,3)17-21-14-10-5-4-9(19)8-12(10)13-11(15(14)22-17)6-7-20-16(13)23/h4-8H,1-3H3,(H,20,23)(H,21,22)

InChI key

VNDWQCSOSCCWIP-UHFFFAOYSA-N

General description

一种有效、可逆、细胞可渗透和ATP竞争性的Janus蛋白酪氨酸激酶（JAKs）抑制剂。显示对JAK1（对于鼠JAK1，IC50=15 nM）、JAK2（IC50=1 nM）、JAK3（Ki=5 nM）和Tyk2（IC50=1 nM）的有效抑制活性。在高得多的浓度下抑制其他激酶。显示抑制IL2和IL4依赖性的CTLL细胞增殖，并阻断STAT5的磷酸化；并且与AG 490（目录编号658401）不同，进一步诱导表达活化的JAKs和STAT3的多发性骨髓瘤细胞的生长抑制。也可获得10 mM（500 µg/162 µl）JAK抑制剂I的DMSO溶液（目录号420097）。
一种有效、细胞可渗透、可逆和ATP竞争性的Janus蛋白酪氨酸激酶（JAKs）抑制剂。显示对JAK1（对于鼠JAK1，IC50=15 nM）、JAK2（IC50=1 nM）、JAK3（Ki=5 nM）和Tyk2（IC50=1 nM）的有效抑制活性。在高得多的浓度下抑制其他激酶。显示抑制IL2和IL4依赖性的CTLL细胞增殖，并阻断STAT5的磷酸化；并且与AG 490（目录编号658401）不同，进一步诱导表达活化的JAKs和STAT3的多发性骨髓瘤细胞的生长抑制。

Biochem/physiol Actions

主要靶标
鼠JAK1
产物与ATP竞争。
可逆性：是
细胞可渗透性：是
靶标IC50：15 nM，针对鼠JAK1；1 nM，针对JAK2；1 nM，针对Tyk2
靶标Ki：5 nM，针对JAK3

Packaging

用惰性气体包装

Preparation Note

复溶后，等分并冷冻（-20°C）。储备溶液在-20°C下可稳定保存至多3个月。

Other Notes

Pedranzini, L., et al. 2006.Cancer Res.66, 9714.
Lucet, I.S., et al. 2005.Blood107, 176.
Thompson, J.E., et al. 2002.Bioorg.Med. Chem. Lett.12, 1219.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

毒性：标准处理（A）

Still not finding the right product?

Explore all of our products under JAK抑制剂I

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

相关内容

Reprogramming Cell Fate and Function Novel Strategies for iPSC Generation, Characterization, and Differentiation
JAK/STAT Signaling Research Focus

The Janus kinase (JAK)/signal transducers and activators of transcription (STAT) signaling pathway plays an important role in cell proliferation, cell differentiation, cell migration, and cell death. It is the principal signaling mechanism for a variety of cytokines and growth factors. Constitutive activation or dysregulation of JAK/STAT signaling can result in inflammatory disease, erythrocytosis, gigantism, and leukemia.

Pathways and Biomarkers of JAK/STAT Signaling

Pathways and Biomarkers of JAK/STAT Signaling

查看所有相关内容
Dongbum Kim et al.
BMB reports, 54(8), 425-430 (2021-04-10)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces coronavirus disease 2019 (COVID-19) and may increase the risk of adverse outcomes in lung cancer patients. In this study, we investigated the expression and function of mucin 1 (MUC1) after SARS-CoV-2 infection
Fuyuko Takata et al.
Journal of cellular biochemistry, 119(11), 9055-9063 (2018-08-05)
Oncostatin M (OSM) is a member of the interleukin (IL)-6 family cytokines. We previously demonstrated that OSM induces blood-brain barrier (BBB) impairment. However, functional characterization of IL-6 family cytokines in BBB regulation and the cytokine-related intracellular signaling pathway remain unclear.
Hannah M Burgess et al.
Genes & development, 35(13-14), 1005-1019 (2021-06-26)
N6-methyladenosine (m6A) is an abundant internal RNA modification, influencing transcript fate and function in uninfected and virus-infected cells. Installation of m6A by the nuclear RNA methyltransferase METTL3 occurs cotranscriptionally; however, the genomes of some cytoplasmic RNA viruses are also m6A-modified.
查看所有相关文献

全球贸易项目编号

货号GTIN
420099-1MG04055977187878
420099-500UG04055977187885